@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

<http://smart.who.int/ig/smart-immunizations/CodeSystem/IMMZ.D1> a fhir:CodeSystem ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "IMMZ.D1"] ; # 
  fhir:text [
     fhir:status [ fhir:v "generated" ] ;
     fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-insensitive code system <code>http://smart.who.int/ig/smart-immunizations/CodeSystem/IMMZ.D1</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">DE109<a name=\"IMMZ.D1-DE109\"> </a></td><td>Birth dose</td><td>Indicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen.</td></tr><tr><td style=\"white-space:nowrap\">DE103<a name=\"IMMZ.D1-DE103\"> </a></td><td>Type of dose</td><td>The type of dose in a series that the client received</td></tr><tr><td style=\"white-space:nowrap\">DE104<a name=\"IMMZ.D1-DE104\"> </a></td><td>Primary series</td><td>Indicates that the client received the primary vaccination series of a product/antigen. This is also applicable for antigens with one dose.</td></tr><tr><td style=\"white-space:nowrap\">DE105<a name=\"IMMZ.D1-DE105\"> </a></td><td>Dose 0</td><td>Indicates that the client received a dose of a product/ antigen within 24 hours of birth. This dose is not a part of the primary vaccination series.</td></tr><tr><td style=\"white-space:nowrap\">DE106<a name=\"IMMZ.D1-DE106\"> </a></td><td>Supplementary dose</td><td>Indicates that the client received a supplementary dose of a product/antigen</td></tr><tr><td style=\"white-space:nowrap\">DE107<a name=\"IMMZ.D1-DE107\"> </a></td><td>Booster dose</td><td>Indicates that the client received booster dose of a product/antigen</td></tr><tr><td style=\"white-space:nowrap\">DE8<a name=\"IMMZ.D1-DE8\"> </a></td><td>Completed the primary vaccination series</td><td>Indicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen.</td></tr><tr><td style=\"white-space:nowrap\">DE102<a name=\"IMMZ.D1-DE102\"> </a></td><td>Completed the booster series</td><td>Indicates if the client has completed the booster series of a product/antigen</td></tr><tr><td style=\"white-space:nowrap\">DE81<a name=\"IMMZ.D1-DE81\"> </a></td><td>Date when primary vaccination series was completed</td><td>The date when the client completed the primary vaccination series (per product/antigen)</td></tr><tr><td style=\"white-space:nowrap\">DE10<a name=\"IMMZ.D1-DE10\"> </a></td><td>HIV status</td><td>The current human immunodeficiency virus (HIV) status of the client</td></tr><tr><td style=\"white-space:nowrap\">DE11<a name=\"IMMZ.D1-DE11\"> </a></td><td>HIV-positive</td><td>The client is known to be HIV positive</td></tr><tr><td style=\"white-space:nowrap\">DE12<a name=\"IMMZ.D1-DE12\"> </a></td><td>HIV-negative</td><td>The client is known to be HIV negative</td></tr><tr><td style=\"white-space:nowrap\">DE13<a name=\"IMMZ.D1-DE13\"> </a></td><td>Unknown</td><td>The client's HIV status is unknown</td></tr><tr><td style=\"white-space:nowrap\">DE15<a name=\"IMMZ.D1-DE15\"> </a></td><td>Preterm birth</td><td>The infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks</td></tr><tr><td style=\"white-space:nowrap\">DE16<a name=\"IMMZ.D1-DE16\"> </a></td><td>Immunocompromised</td><td>The client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases</td></tr><tr><td style=\"white-space:nowrap\">DE17<a name=\"IMMZ.D1-DE17\"> </a></td><td>Currently on ART</td><td>The client is currently receiving antiretroviral therapy (ART)</td></tr><tr><td style=\"white-space:nowrap\">DE84<a name=\"IMMZ.D1-DE84\"> </a></td><td>Type of TB infection test performed</td><td>The type of TB infection test performed</td></tr><tr><td style=\"white-space:nowrap\">DE85<a name=\"IMMZ.D1-DE85\"> </a></td><td>IGRA</td><td>Interferon-gamma release assay (IGRA)</td></tr><tr><td style=\"white-space:nowrap\">DE86<a name=\"IMMZ.D1-DE86\"> </a></td><td>TST</td><td>Tuberculin skin test (TST)</td></tr><tr><td style=\"white-space:nowrap\">DE87<a name=\"IMMZ.D1-DE87\"> </a></td><td>TB infection test result</td><td>Records the result of the TB infection test</td></tr><tr><td style=\"white-space:nowrap\">DE88<a name=\"IMMZ.D1-DE88\"> </a></td><td>Positive</td><td>Test result was positive</td></tr><tr><td style=\"white-space:nowrap\">DE89<a name=\"IMMZ.D1-DE89\"> </a></td><td>Negative</td><td>Test result was negative</td></tr><tr><td style=\"white-space:nowrap\">DE93<a name=\"IMMZ.D1-DE93\"> </a></td><td>Immunologically stable</td><td>The client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines</td></tr><tr><td style=\"white-space:nowrap\">DE94<a name=\"IMMZ.D1-DE94\"> </a></td><td>Clinically well</td><td>The client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging</td></tr><tr><td style=\"white-space:nowrap\">DE29<a name=\"IMMZ.D1-DE29\"> </a></td><td>Birth weight in grams</td><td>Represents the client's birth weight value measures in grams</td></tr><tr><td style=\"white-space:nowrap\">DE35<a name=\"IMMZ.D1-DE35\"> </a></td><td>Type of polio dose</td><td>The type of the polio vaccine dose administered to the client</td></tr><tr><td style=\"white-space:nowrap\">DE36<a name=\"IMMZ.D1-DE36\"> </a></td><td>IPV</td><td>Inactivated poliovirus vaccine (IPV)</td></tr><tr><td style=\"white-space:nowrap\">DE37<a name=\"IMMZ.D1-DE37\"> </a></td><td>bOPV</td><td>Bivalent oral poliovirus vaccine (bOPV)</td></tr><tr><td style=\"white-space:nowrap\">DE92<a name=\"IMMZ.D1-DE92\"> </a></td><td>Severely immunosuppressed</td><td>The client is known to be severely immunosuppressed</td></tr><tr><td style=\"white-space:nowrap\">DE49<a name=\"IMMZ.D1-DE49\"> </a></td><td>ART start date</td><td>The date on which the client started or restarted antiretroviral therapy (ART)</td></tr><tr><td style=\"white-space:nowrap\">DE96<a name=\"IMMZ.D1-DE96\"> </a></td><td>High risk of pneumococcal infection</td><td>The client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease)</td></tr><tr><td style=\"white-space:nowrap\">DE52<a name=\"IMMZ.D1-DE52\"> </a></td><td>Type of JE dose</td><td>The type of Japanese encephalitis (JE) vaccine dose administered to the client</td></tr><tr><td style=\"white-space:nowrap\">DE53<a name=\"IMMZ.D1-DE53\"> </a></td><td>Inactivated Vero cell-derived vaccine</td><td>Inactivated Vero cell-derived Japanese encephalitis (JE) vaccine type</td></tr><tr><td style=\"white-space:nowrap\">DE54<a name=\"IMMZ.D1-DE54\"> </a></td><td>Live attenuated vaccine</td><td>Live attenuated Japanese encephalitis (JE) vaccine type</td></tr><tr><td style=\"white-space:nowrap\">DE55<a name=\"IMMZ.D1-DE55\"> </a></td><td>Live recombinant vaccine</td><td>Live recombinant Japanese encephalitis (JE) vaccine type</td></tr><tr><td style=\"white-space:nowrap\">DE56<a name=\"IMMZ.D1-DE56\"> </a></td><td>Type of TBE dose</td><td>The type of tick-borne encephalitis (TBE) vaccine dose administered</td></tr><tr><td style=\"white-space:nowrap\">DE57<a name=\"IMMZ.D1-DE57\"> </a></td><td>FSME-Immun</td><td>FSME-Immun vaccine product, which is an inactivated whole-virus vaccine for tick-borne encephalitis (TBE)</td></tr><tr><td style=\"white-space:nowrap\">DE58<a name=\"IMMZ.D1-DE58\"> </a></td><td>Encepur</td><td>Encepur vaccine product, which is an inactivated viral vaccine for tick-borne encephalitis (TBE)</td></tr><tr><td style=\"white-space:nowrap\">DE59<a name=\"IMMZ.D1-DE59\"> </a></td><td>TBE-Moscow</td><td>TBE-Moscow vaccine product, which is a vaccine for tick-borne encephalitis (TBE)</td></tr><tr><td style=\"white-space:nowrap\">DE60<a name=\"IMMZ.D1-DE60\"> </a></td><td>EnceVir</td><td>EnceVir vaccine product, which is a vaccine for tick-borne encephalitis (TBE)</td></tr><tr><td style=\"white-space:nowrap\">DE61<a name=\"IMMZ.D1-DE61\"> </a></td><td>Type of typhoid dose</td><td>The type of typhoid vaccine dose administered to the client</td></tr><tr><td style=\"white-space:nowrap\">DE62<a name=\"IMMZ.D1-DE62\"> </a></td><td>Typbar-TCV</td><td>Typbar-TCV vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE63<a name=\"IMMZ.D1-DE63\"> </a></td><td>ViPS</td><td>Vi polysaccharide (ViPS) vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE64<a name=\"IMMZ.D1-DE64\"> </a></td><td>Ty21a</td><td>Ty21a vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE65<a name=\"IMMZ.D1-DE65\"> </a></td><td>Type of cholera dose</td><td>The type of cholera vaccine dose administered to the client</td></tr><tr><td style=\"white-space:nowrap\">DE66<a name=\"IMMZ.D1-DE66\"> </a></td><td>WC vaccine</td><td>Killed whole cell (WC) only cholera vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE67<a name=\"IMMZ.D1-DE67\"> </a></td><td>WC-rBS vaccine</td><td>Vaccine contains a mixture of the recombinant B subunit (rBS) of cholera toxin plus killed whole cell (WC)</td></tr><tr><td style=\"white-space:nowrap\">DE68<a name=\"IMMZ.D1-DE68\"> </a></td><td>Type of meningococcal dose</td><td>The type of meningococcal vaccine dose administered to the client</td></tr><tr><td style=\"white-space:nowrap\">DE69<a name=\"IMMZ.D1-DE69\"> </a></td><td>MenA conjugate vaccine (5µg)</td><td>Monovalent serogroup A (MenA) conjugate vaccine (5µg) vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE70<a name=\"IMMZ.D1-DE70\"> </a></td><td>Monovalent MenC conjugate</td><td>Monovalent MenC conjugate vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE71<a name=\"IMMZ.D1-DE71\"> </a></td><td>Quadrivalent conjugate</td><td>Quadrivalent conjugate (A,C,W135,Y-D and A,C,W135,Y-CRM) vaccines</td></tr><tr><td style=\"white-space:nowrap\">DE97<a name=\"IMMZ.D1-DE97\"> </a></td><td>Polysaccharide vaccine</td><td>Polysaccharide vaccines not including polysaccharide-protein conjugate vaccines</td></tr><tr><td style=\"white-space:nowrap\">DE72<a name=\"IMMZ.D1-DE72\"> </a></td><td>Age in months when client received first meningococcal dose</td><td>The age in months when client received their first meningococcal dose</td></tr><tr><td style=\"white-space:nowrap\">DE73<a name=\"IMMZ.D1-DE73\"> </a></td><td>Type of hepatitis A dose</td><td>The type of hepatitis A vaccine dose administered to the client</td></tr><tr><td style=\"white-space:nowrap\">DE74<a name=\"IMMZ.D1-DE74\"> </a></td><td>Live attenuated hepatitis A vaccine</td><td>Live attenuated hepatitis A vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE75<a name=\"IMMZ.D1-DE75\"> </a></td><td>Inactivated hepatitis A vaccine</td><td>Inactivated hepatitis A vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE99<a name=\"IMMZ.D1-DE99\"> </a></td><td>Type of hepatitis B dose</td><td>The type of hepatitis B vaccine dose administered to the client</td></tr><tr><td style=\"white-space:nowrap\">DE100<a name=\"IMMZ.D1-DE100\"> </a></td><td>Hepatitis B monovalent vaccine</td><td>Hepatitis B monovalent vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE101<a name=\"IMMZ.D1-DE101\"> </a></td><td>Hepatitis B combination vaccine</td><td>Hepatitis B combination vaccine</td></tr><tr><td style=\"white-space:nowrap\">DE76<a name=\"IMMZ.D1-DE76\"> </a></td><td>VNA level</td><td>Vaccine-induced neutralizing (VNA) antibody level. It is a measured as a serum antibody concentration amount observed from the result of the concentrated, purified cell culture and embryonated egg-based rabies vaccines (CCEEV)</td></tr><tr><td style=\"white-space:nowrap\">DE98<a name=\"IMMZ.D1-DE98\"> </a></td><td>Risk of occupational exposure to rabies virus</td><td>Professional at risk of occupational exposure to rabies virus, particularly animal health-care workers. Also considered for medical professionals who regularly provide care to persons with rabies.</td></tr><tr><td style=\"white-space:nowrap\">DE77<a name=\"IMMZ.D1-DE77\"> </a></td><td>Dengue serostatus</td><td>Indicates the result of a serological test determining whether the client has antibodies against the dengue virus</td></tr><tr><td style=\"white-space:nowrap\">DE110<a name=\"IMMZ.D1-DE110\"> </a></td><td>Positive</td><td>The client has detectable antibodies against the dengue virus, suggesting past exposure or vaccination</td></tr><tr><td style=\"white-space:nowrap\">DE111<a name=\"IMMZ.D1-DE111\"> </a></td><td>Negative</td><td>The client does not have detectable antibodies, indicating no previous exposure or vaccination against the dengue virus</td></tr><tr><td style=\"white-space:nowrap\">DE112<a name=\"IMMZ.D1-DE112\"> </a></td><td>Unknown</td><td>The client's dengue serostatus is unknown</td></tr></table></div>"
  ] ; # 
  fhir:url [ fhir:v "http://smart.who.int/ig/smart-immunizations/CodeSystem/IMMZ.D1"^^xsd:anyURI] ; # 
  fhir:version [ fhir:v "0.1.0"] ; # 
  fhir:name [ fhir:v "IMMZ_D1"] ; # 
  fhir:title [ fhir:v "IMMZ.D1 CodeSystem for Data Elements"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:experimental [ fhir:v "false"^^xsd:boolean] ; # 
  fhir:date [ fhir:v "2024-04-04T07:29:23+00:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "World Health Organization (WHO)"] ; # 
  fhir:contact ( [
     fhir:name [ fhir:v "World Health Organization (WHO)" ] ;
     fhir:telecom ( [
       fhir:system [ fhir:v "url" ] ;
       fhir:value [ fhir:v "https://www.who.int" ]
     ] )
  ] ) ; # 
  fhir:description [ fhir:v "CodeSystem for IMMZ.D1 Data Elements"] ; # 
  fhir:jurisdiction ( [
     fhir:coding ( [
       fhir:system [ fhir:v "http://unstats.un.org/unsd/methods/m49/m49.htm"^^xsd:anyURI ] ;
       fhir:code [ fhir:v "001" ]
     ] )
  ] ) ; # 
  fhir:caseSensitive [ fhir:v "false"^^xsd:boolean] ; # 
  fhir:content [ fhir:v "complete"] ; # 
  fhir:count [ fhir:v "65"^^xsd:nonNegativeInteger] ; # 
  fhir:concept ( [
     fhir:code [ fhir:v "DE109" ] ;
     fhir:display [ fhir:v "Birth dose" ] ;
     fhir:definition [ fhir:v "Indicates if the client received a dose within 24 hours of birth. Whether a birth dose is counted as part of the primary series will depend on the antigen." ]
  ] [
     fhir:code [ fhir:v "DE103" ] ;
     fhir:display [ fhir:v "Type of dose" ] ;
     fhir:definition [ fhir:v "The type of dose in a series that the client received" ]
  ] [
     fhir:code [ fhir:v "DE104" ] ;
     fhir:display [ fhir:v "Primary series" ] ;
     fhir:definition [ fhir:v "Indicates that the client received the primary vaccination series of a product/antigen. This is also applicable for antigens with one dose." ]
  ] [
     fhir:code [ fhir:v "DE105" ] ;
     fhir:display [ fhir:v "Dose 0" ] ;
     fhir:definition [ fhir:v "Indicates that the client received a dose of a product/ antigen within 24 hours of birth. This dose is not a part of the primary vaccination series." ]
  ] [
     fhir:code [ fhir:v "DE106" ] ;
     fhir:display [ fhir:v "Supplementary dose" ] ;
     fhir:definition [ fhir:v "Indicates that the client received a supplementary dose of a product/antigen" ]
  ] [
     fhir:code [ fhir:v "DE107" ] ;
     fhir:display [ fhir:v "Booster dose" ] ;
     fhir:definition [ fhir:v "Indicates that the client received booster dose of a product/antigen" ]
  ] [
     fhir:code [ fhir:v "DE8" ] ;
     fhir:display [ fhir:v "Completed the primary vaccination series" ] ;
     fhir:definition [ fhir:v "Indicates if the client has completed the primary vaccination series of a product/antigen. If the client has not yet completed their primary series, it means they may be expected to receive more doses to complete their vaccination regimen for the respective product/antigen." ]
  ] [
     fhir:code [ fhir:v "DE102" ] ;
     fhir:display [ fhir:v "Completed the booster series" ] ;
     fhir:definition [ fhir:v "Indicates if the client has completed the booster series of a product/antigen" ]
  ] [
     fhir:code [ fhir:v "DE81" ] ;
     fhir:display [ fhir:v "Date when primary vaccination series was completed" ] ;
     fhir:definition [ fhir:v "The date when the client completed the primary vaccination series (per product/antigen)" ]
  ] [
     fhir:code [ fhir:v "DE10" ] ;
     fhir:display [ fhir:v "HIV status" ] ;
     fhir:definition [ fhir:v "The current human immunodeficiency virus (HIV) status of the client" ]
  ] [
     fhir:code [ fhir:v "DE11" ] ;
     fhir:display [ fhir:v "HIV-positive" ] ;
     fhir:definition [ fhir:v "The client is known to be HIV positive" ]
  ] [
     fhir:code [ fhir:v "DE12" ] ;
     fhir:display [ fhir:v "HIV-negative" ] ;
     fhir:definition [ fhir:v "The client is known to be HIV negative" ]
  ] [
     fhir:code [ fhir:v "DE13" ] ;
     fhir:display [ fhir:v "Unknown" ] ;
     fhir:definition [ fhir:v "The client's HIV status is unknown" ]
  ] [
     fhir:code [ fhir:v "DE15" ] ;
     fhir:display [ fhir:v "Preterm birth" ] ;
     fhir:definition [ fhir:v "The infant was preterm; the mother gave birth to the infant when gestational age was less than 37 weeks" ]
  ] [
     fhir:code [ fhir:v "DE16" ] ;
     fhir:display [ fhir:v "Immunocompromised" ] ;
     fhir:definition [ fhir:v "The client is known to be immunocompromised. This means the client has a weakened immune system and having a reduced ability to fight infections and other diseases" ]
  ] [
     fhir:code [ fhir:v "DE17" ] ;
     fhir:display [ fhir:v "Currently on ART" ] ;
     fhir:definition [ fhir:v "The client is currently receiving antiretroviral therapy (ART)" ]
  ] [
     fhir:code [ fhir:v "DE84" ] ;
     fhir:display [ fhir:v "Type of TB infection test performed" ] ;
     fhir:definition [ fhir:v "The type of TB infection test performed" ]
  ] [
     fhir:code [ fhir:v "DE85" ] ;
     fhir:display [ fhir:v "IGRA" ] ;
     fhir:definition [ fhir:v "Interferon-gamma release assay (IGRA)" ]
  ] [
     fhir:code [ fhir:v "DE86" ] ;
     fhir:display [ fhir:v "TST" ] ;
     fhir:definition [ fhir:v "Tuberculin skin test (TST)" ]
  ] [
     fhir:code [ fhir:v "DE87" ] ;
     fhir:display [ fhir:v "TB infection test result" ] ;
     fhir:definition [ fhir:v "Records the result of the TB infection test" ]
  ] [
     fhir:code [ fhir:v "DE88" ] ;
     fhir:display [ fhir:v "Positive" ] ;
     fhir:definition [ fhir:v "Test result was positive" ]
  ] [
     fhir:code [ fhir:v "DE89" ] ;
     fhir:display [ fhir:v "Negative" ] ;
     fhir:definition [ fhir:v "Test result was negative" ]
  ] [
     fhir:code [ fhir:v "DE93" ] ;
     fhir:display [ fhir:v "Immunologically stable" ] ;
     fhir:definition [ fhir:v "The client is living with HIV and is immunologically stable with CD4 count or percentage above a minimum as defined in the HIV guidelines" ]
  ] [
     fhir:code [ fhir:v "DE94" ] ;
     fhir:display [ fhir:v "Clinically well" ] ;
     fhir:definition [ fhir:v "The client is living with HIV and is clinically well, as defined in HIV guidelines and WHO clinical staging" ]
  ] [
     fhir:code [ fhir:v "DE29" ] ;
     fhir:display [ fhir:v "Birth weight in grams" ] ;
     fhir:definition [ fhir:v "Represents the client's birth weight value measures in grams" ]
  ] [
     fhir:code [ fhir:v "DE35" ] ;
     fhir:display [ fhir:v "Type of polio dose" ] ;
     fhir:definition [ fhir:v "The type of the polio vaccine dose administered to the client" ]
  ] [
     fhir:code [ fhir:v "DE36" ] ;
     fhir:display [ fhir:v "IPV" ] ;
     fhir:definition [ fhir:v "Inactivated poliovirus vaccine (IPV)" ]
  ] [
     fhir:code [ fhir:v "DE37" ] ;
     fhir:display [ fhir:v "bOPV" ] ;
     fhir:definition [ fhir:v "Bivalent oral poliovirus vaccine (bOPV)" ]
  ] [
     fhir:code [ fhir:v "DE92" ] ;
     fhir:display [ fhir:v "Severely immunosuppressed" ] ;
     fhir:definition [ fhir:v "The client is known to be severely immunosuppressed" ]
  ] [
     fhir:code [ fhir:v "DE49" ] ;
     fhir:display [ fhir:v "ART start date" ] ;
     fhir:definition [ fhir:v "The date on which the client started or restarted antiretroviral therapy (ART)" ]
  ] [
     fhir:code [ fhir:v "DE96" ] ;
     fhir:display [ fhir:v "High risk of pneumococcal infection" ] ;
     fhir:definition [ fhir:v "The client is at high risk for pneumococcal infection because of underlying medical conditions (i.e. HIV infection or sickle-cell disease)" ]
  ] [
     fhir:code [ fhir:v "DE52" ] ;
     fhir:display [ fhir:v "Type of JE dose" ] ;
     fhir:definition [ fhir:v "The type of Japanese encephalitis (JE) vaccine dose administered to the client" ]
  ] [
     fhir:code [ fhir:v "DE53" ] ;
     fhir:display [ fhir:v "Inactivated Vero cell-derived vaccine" ] ;
     fhir:definition [ fhir:v "Inactivated Vero cell-derived Japanese encephalitis (JE) vaccine type" ]
  ] [
     fhir:code [ fhir:v "DE54" ] ;
     fhir:display [ fhir:v "Live attenuated vaccine" ] ;
     fhir:definition [ fhir:v "Live attenuated Japanese encephalitis (JE) vaccine type" ]
  ] [
     fhir:code [ fhir:v "DE55" ] ;
     fhir:display [ fhir:v "Live recombinant vaccine" ] ;
     fhir:definition [ fhir:v "Live recombinant Japanese encephalitis (JE) vaccine type" ]
  ] [
     fhir:code [ fhir:v "DE56" ] ;
     fhir:display [ fhir:v "Type of TBE dose" ] ;
     fhir:definition [ fhir:v "The type of tick-borne encephalitis (TBE) vaccine dose administered" ]
  ] [
     fhir:code [ fhir:v "DE57" ] ;
     fhir:display [ fhir:v "FSME-Immun" ] ;
     fhir:definition [ fhir:v "FSME-Immun vaccine product, which is an inactivated whole-virus vaccine for tick-borne encephalitis (TBE)" ]
  ] [
     fhir:code [ fhir:v "DE58" ] ;
     fhir:display [ fhir:v "Encepur" ] ;
     fhir:definition [ fhir:v "Encepur vaccine product, which is an inactivated viral vaccine for tick-borne encephalitis (TBE)" ]
  ] [
     fhir:code [ fhir:v "DE59" ] ;
     fhir:display [ fhir:v "TBE-Moscow" ] ;
     fhir:definition [ fhir:v "TBE-Moscow vaccine product, which is a vaccine for tick-borne encephalitis (TBE)" ]
  ] [
     fhir:code [ fhir:v "DE60" ] ;
     fhir:display [ fhir:v "EnceVir" ] ;
     fhir:definition [ fhir:v "EnceVir vaccine product, which is a vaccine for tick-borne encephalitis (TBE)" ]
  ] [
     fhir:code [ fhir:v "DE61" ] ;
     fhir:display [ fhir:v "Type of typhoid dose" ] ;
     fhir:definition [ fhir:v "The type of typhoid vaccine dose administered to the client" ]
  ] [
     fhir:code [ fhir:v "DE62" ] ;
     fhir:display [ fhir:v "Typbar-TCV" ] ;
     fhir:definition [ fhir:v "Typbar-TCV vaccine" ]
  ] [
     fhir:code [ fhir:v "DE63" ] ;
     fhir:display [ fhir:v "ViPS" ] ;
     fhir:definition [ fhir:v "Vi polysaccharide (ViPS) vaccine" ]
  ] [
     fhir:code [ fhir:v "DE64" ] ;
     fhir:display [ fhir:v "Ty21a" ] ;
     fhir:definition [ fhir:v "Ty21a vaccine" ]
  ] [
     fhir:code [ fhir:v "DE65" ] ;
     fhir:display [ fhir:v "Type of cholera dose" ] ;
     fhir:definition [ fhir:v "The type of cholera vaccine dose administered to the client" ]
  ] [
     fhir:code [ fhir:v "DE66" ] ;
     fhir:display [ fhir:v "WC vaccine" ] ;
     fhir:definition [ fhir:v "Killed whole cell (WC) only cholera vaccine" ]
  ] [
     fhir:code [ fhir:v "DE67" ] ;
     fhir:display [ fhir:v "WC-rBS vaccine" ] ;
     fhir:definition [ fhir:v "Vaccine contains a mixture of the recombinant B subunit (rBS) of cholera toxin plus killed whole cell (WC)" ]
  ] [
     fhir:code [ fhir:v "DE68" ] ;
     fhir:display [ fhir:v "Type of meningococcal dose" ] ;
     fhir:definition [ fhir:v "The type of meningococcal vaccine dose administered to the client" ]
  ] [
     fhir:code [ fhir:v "DE69" ] ;
     fhir:display [ fhir:v "MenA conjugate vaccine (5µg)" ] ;
     fhir:definition [ fhir:v "Monovalent serogroup A (MenA) conjugate vaccine (5µg) vaccine" ]
  ] [
     fhir:code [ fhir:v "DE70" ] ;
     fhir:display [ fhir:v "Monovalent MenC conjugate" ] ;
     fhir:definition [ fhir:v "Monovalent MenC conjugate vaccine" ]
  ] [
     fhir:code [ fhir:v "DE71" ] ;
     fhir:display [ fhir:v "Quadrivalent conjugate" ] ;
     fhir:definition [ fhir:v "Quadrivalent conjugate (A,C,W135,Y-D and A,C,W135,Y-CRM) vaccines" ]
  ] [
     fhir:code [ fhir:v "DE97" ] ;
     fhir:display [ fhir:v "Polysaccharide vaccine" ] ;
     fhir:definition [ fhir:v "Polysaccharide vaccines not including polysaccharide-protein conjugate vaccines" ]
  ] [
     fhir:code [ fhir:v "DE72" ] ;
     fhir:display [ fhir:v "Age in months when client received first meningococcal dose" ] ;
     fhir:definition [ fhir:v "The age in months when client received their first meningococcal dose" ]
  ] [
     fhir:code [ fhir:v "DE73" ] ;
     fhir:display [ fhir:v "Type of hepatitis A dose" ] ;
     fhir:definition [ fhir:v "The type of hepatitis A vaccine dose administered to the client" ]
  ] [
     fhir:code [ fhir:v "DE74" ] ;
     fhir:display [ fhir:v "Live attenuated hepatitis A vaccine" ] ;
     fhir:definition [ fhir:v "Live attenuated hepatitis A vaccine" ]
  ] [
     fhir:code [ fhir:v "DE75" ] ;
     fhir:display [ fhir:v "Inactivated hepatitis A vaccine" ] ;
     fhir:definition [ fhir:v "Inactivated hepatitis A vaccine" ]
  ] [
     fhir:code [ fhir:v "DE99" ] ;
     fhir:display [ fhir:v "Type of hepatitis B dose" ] ;
     fhir:definition [ fhir:v "The type of hepatitis B vaccine dose administered to the client" ]
  ] [
     fhir:code [ fhir:v "DE100" ] ;
     fhir:display [ fhir:v "Hepatitis B monovalent vaccine" ] ;
     fhir:definition [ fhir:v "Hepatitis B monovalent vaccine" ]
  ] [
     fhir:code [ fhir:v "DE101" ] ;
     fhir:display [ fhir:v "Hepatitis B combination vaccine" ] ;
     fhir:definition [ fhir:v "Hepatitis B combination vaccine" ]
  ] [
     fhir:code [ fhir:v "DE76" ] ;
     fhir:display [ fhir:v "VNA level" ] ;
     fhir:definition [ fhir:v "Vaccine-induced neutralizing (VNA) antibody level. It is a measured as a serum antibody concentration amount observed from the result of the concentrated, purified cell culture and embryonated egg-based rabies vaccines (CCEEV)" ]
  ] [
     fhir:code [ fhir:v "DE98" ] ;
     fhir:display [ fhir:v "Risk of occupational exposure to rabies virus" ] ;
     fhir:definition [ fhir:v "Professional at risk of occupational exposure to rabies virus, particularly animal health-care workers. Also considered for medical professionals who regularly provide care to persons with rabies." ]
  ] [
     fhir:code [ fhir:v "DE77" ] ;
     fhir:display [ fhir:v "Dengue serostatus" ] ;
     fhir:definition [ fhir:v "Indicates the result of a serological test determining whether the client has antibodies against the dengue virus" ]
  ] [
     fhir:code [ fhir:v "DE110" ] ;
     fhir:display [ fhir:v "Positive" ] ;
     fhir:definition [ fhir:v "The client has detectable antibodies against the dengue virus, suggesting past exposure or vaccination" ]
  ] [
     fhir:code [ fhir:v "DE111" ] ;
     fhir:display [ fhir:v "Negative" ] ;
     fhir:definition [ fhir:v "The client does not have detectable antibodies, indicating no previous exposure or vaccination against the dengue virus" ]
  ] [
     fhir:code [ fhir:v "DE112" ] ;
     fhir:display [ fhir:v "Unknown" ] ;
     fhir:definition [ fhir:v "The client's dengue serostatus is unknown" ]
  ] ) . # 

# -------------------------------------------------------------------------------------

